您当前的位置:首页 > 放射诊断 > CT诊断

经静脉注射FX530对实验性兔VX2肝癌超声造影的研究

时间:2006-12-18 18:04:24  来源:  作者:

 <?xml:namespace prefix = o ns = "urn:schemas-microsoft-com:office:office" />

Ultrasonographic study of experimental rabbit VX2 liver carcinomas by intravenous injection of FX530

 

张青萍 柳建华 周翔 周玉清 乐桂蓉

430030 武汉,同济医科大学附属同济医院超声科

ZHANG Qingping,LIU Jianhua,ZHOU Xiang,et al.Dept.of Ultrasound,Tongji Hospital,Tongji Medical University,Wuhan 430030

 

Abstract

  Objective:To investigate the efficacy of ultrasonography observing the experimental rabbit VX2 liver carcinomas by intravenous administration of ultrasonographic contrast agent FX530.

  Methods:The animal models of transplanted VX2 carcinomas in the livers of 15 rabbits (20 nodules) were prepared.After intravenous injection of FX530,grey scale ultrasonography was used to observe the enhancememt of liver textures and VX2 liver carcinomas.

  Results:After injection,grey scale ultrasonography of the liver parenchyma,arteries and portal veins in the liver and the carcinoma vascularities were well enhanced.As the tumor tissue was slightly enhanced or not enhanced,the visibility of the VX2 carcinomas was greatly improved,even very small carcinomas could be detected.

  Conclusions:Intravenous ultrasonographic contrast agent could improve the visualization of hepatic carcinoma.

  Key words:Ultrasonography,interventional Contrast media Liver neoplasms,experimental

 

  肝癌是我国较常见且恶性程度很高的恶性肿瘤之一,肝癌早期诊断主要依赖各种影像学方法和血清甲胎蛋白的检测。近年来。由于新型声学造影剂及其相关技术的发展,使超声对小肝癌的检出率明显提高1,2]。本研究观察应用新型声学造影剂FX530对兔肝脏和实验性兔VX2肝癌的增强效果,现报道如下。

 

  材料与方法

来顶一下
返回首页
返回首页
 
推荐资讯
掌间筑未来,西门子医疗推出全新CT产品SOMATOM go.
掌间筑未来,西门子医疗
“智”动创新 共享“健康中国” 西门子医疗亮相2017 HOSPEQ
“智”动创新 共享“
西门子医疗携一系列创新成果亮相CMEF 2017   助力“智慧”医疗服务建设
西门子医疗携一系列创
西门子医疗中国亮相第77届中国国际医疗器械春季博览会,多方位展示互联网时代下 “智慧”成果
西门子医疗中国亮相第
最后更新
热门点击
  1. 小肠重复畸形2例
  2. 胰腺导管内乳头状黏液性肿瘤1例
  3. CT诊断特发性肝动静脉畸形1例
  4. 急性单纯性憩室炎诊断:超声完胜 CT
  5. 影像学新进展:非钙化斑块的 CT 测量
  6. TAVI 手术成功需要「软硬兼施」的 CT
  7. CT导向下近距放疗对肺癌的研究
  8. CT增强扫描中的相关概念总结
  9. 腹部CT扫描规范指南(中华医学会)
  10. CT检查对于胸部哪些疾病诊断有价值?